Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDO2 | P48775 | 1/20 | 0.40 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.40 |
| ▸ | GRM5 | P41594 | 6/20 | 0.39 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.38 |
| ▸ | NEK1 | Q96PY6 | 1/20 | 0.37 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.36 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.36 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.36 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21758238 | 0.96 | CLK4 (0.43) | TDO2CLK4GRM5MAP4K4NEK1 | |
| SCHEMBL21758351 | 0.95 | TDO2 (0.36) | TDO2CLK4GRM5ALDH1A3KCNN4 | |
| SCHEMBL21758520 | 0.94 | GRM5 (0.35) | TDO2CLK4GRM5MAP4K4NEK1 | |
| SCHEMBL21758517 | 0.94 | TDO2 (0.38) | TDO2MAP4K4PDE10A | |
| SCHEMBL21758234 | 0.92 | ELANE (0.39) | TDO2CLK4GRM5ALDH1A3CYP1A2 | |
| SCHEMBL21758359 | 0.92 | GABRA1 (0.36) | TDO2CLK4GRM5MAP4K4NEK1 | |
| SCHEMBL23348004 | 0.91 | ABCG2 (0.41) | TDO2CLK4GRM5ALDH1A3CYP1A2 | |
| SCHEMBL21758229 | 0.90 | DDB1 (0.40) | TDO2CLK4ALDH1A1 | |
| SCHEMBL21758233 | 0.90 | PTGER4 (0.37) | TDO2ELANE | |
| SCHEMBL21758514 | 0.89 | GRM5 (0.35) | TDO2CLK4GRM5MAP4K4NEK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OXER1, OR10J3, OXGR1 | TDO2 89/4885CLK4 3016/4885GRM5 3349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.